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Background: Angioscopic studies have shown heterogeneous as well as incomplete neointimal coverage (NIC) was associated with subclinical 
thrombosis, thereby implicating a risk of late stent thrombosis in the first generation drug-eluting stents. We angioscopically compared the 
heterogeneity of NIC in zotarolimus-eluting stents (ZES) with that in the first generation drug-eluting stents: sirolimus-eluting stents (SES) and 
paclitaxel-eluting stents (PES).
Methods: Angioscopy was performed approximately 8 months after 16 SES, 17 PES and 14 ZES stenting, which were implanted initially in the 
native coronary artery in patients with stable angina pectoris. Dominant NIC grade and heterogeneity of the NIC were assessed. Neointimal coverage 
was graded: grade 0 = fully visible struts; grade 1 = struts bulged into the lumen, but were covered and still transparently visible; grade 2 = struts 
were embedded but were seen translucently; grade 3 = struts were fully embedded and invisible. Heterogeneity was judged when different NIC 
grades of more than or equal to 1 grade were present. Degree of heterogeneity was defined as difference between minimum grades and maximum 
grades.
Results: The dominant NIC grade was significantly different among the stents (1.3 ± 0.7 in SES, 2.1 ± 1.1 in PES, 2.7 ± 0.5 in ZES, P=0.0002). ZES 
showed higher grades of NIC than SES (P<0.0001), while PES and ZES showed similar NIC. Homogeneous coverage was seen in 50% of SES, in 18% 
of PES, and in 71% of ZES (P=0.01). Degree of heterogeneity was also different among the stents (0.6 ± 0.6 in SES, 1.0 ± 0.6 in PES, 0.3 ± 0.5 in 
ZES, P=0.005). NIC was more heterogeneous in PES than in ZES (P=0.001), whereas degree of heterogeneity was similar between SES and ZES.
Conclusions: Among the drug-eluting stents compared, ZES achieved both homogeneous and complete neointimal coverage.
